Ignite Creation Date:
2025-12-25 @ 2:36 AM
Ignite Modification Date:
2026-03-03 @ 2:04 AM
Study NCT ID:
NCT05128734
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-15
First Post:
2021-10-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)
Sponsor:
AHS Cancer Control Alberta
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TMZ-TNBC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None